Sonova Holding AG (SONVY)
USD 65.17
(0.11%)
USD 65.17
(0.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.28 Billion CHF | -8.56% |
| 2023 | 1.4 Billion CHF | 60.32% |
| 2022 | 873.8 Million CHF | 1318.51% |
| 2021 | 61.6 Million CHF | -89.87% |
| 2020 | 608.1 Million CHF | 158.77% |
| 2019 | 235 Million CHF | 13.37% |
| 2018 | 207.28 Million CHF | -48.92% |
| 2017 | 405.81 Million CHF | 237.31% |
| 2016 | -295.54 Million CHF | 24.28% |
| 2015 | -390.33 Million CHF | -18.28% |
| 2014 | -330 Million CHF | -60.38% |
| 2013 | -205.76 Million CHF | -412.4% |
| 2012 | 65.86 Million CHF | -36.03% |
| 2011 | 102.96 Million CHF | -21.9% |
| 2010 | 131.83 Million CHF | 161.13% |
| 2009 | -215.65 Million CHF | 27.27% |
| 2008 | -296.52 Million CHF | -4.31% |
| 2007 | -284.27 Million CHF | -70.41% |
| 2006 | -166.82 Million CHF | -101.46% |
| 2005 | -82.8 Million CHF | -127.99% |
| 2004 | -36.31 Million CHF | -161.02% |
| 2003 | 59.51 Million CHF | -35.73% |
| 2002 | 92.6 Million CHF | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 1.28 Billion CHF | -23.47% |
| 2024 FY | 1.28 Billion CHF | -8.56% |
| 2024 Q2 | 1.67 Billion CHF | 19.49% |
| 2023 FY | 1.4 Billion CHF | 60.32% |
| 2023 Q2 | 1.5 Billion CHF | 71.69% |
| 2023 Q4 | 1.4 Billion CHF | -6.62% |
| 2022 FY | 873.8 Million CHF | 1318.51% |
| 2022 Q2 | 346.3 Million CHF | 462.18% |
| 2022 Q4 | 873.8 Million CHF | 152.32% |
| 2021 FY | 61.6 Million CHF | -89.87% |
| 2021 Q4 | 61.6 Million CHF | -85.54% |
| 2021 Q2 | 426 Million CHF | -29.95% |
| 2020 Q4 | 608.1 Million CHF | -19.64% |
| 2020 Q2 | 756.7 Million CHF | 222.0% |
| 2020 FY | 608.1 Million CHF | 158.77% |
| 2019 Q4 | 235 Million CHF | -19.18% |
| 2019 Q2 | 290.75 Million CHF | 40.26% |
| 2019 FY | 235 Million CHF | 13.37% |
| 2018 Q2 | 489.47 Million CHF | 27.21% |
| 2018 FY | 207.28 Million CHF | -48.92% |
| 2018 Q4 | 207.3 Million CHF | -57.65% |
| 2017 Q2 | 674.85 Million CHF | 312.81% |
| 2017 Q4 | 384.79 Million CHF | -42.98% |
| 2017 FY | 405.81 Million CHF | 237.31% |
| 2016 FY | -295.54 Million CHF | 24.28% |
| 2016 Q4 | -317.12 Million CHF | -71.93% |
| 2016 Q2 | -184.45 Million CHF | 52.75% |
| 2015 Q2 | -301.37 Million CHF | 8.68% |
| 2015 FY | -390.33 Million CHF | -18.28% |
| 2015 Q4 | -390.33 Million CHF | -29.52% |
| 2014 Q4 | -330 Million CHF | -83.1% |
| 2014 Q2 | -180.23 Million CHF | 12.41% |
| 2014 FY | -330 Million CHF | -60.38% |
| 2013 Q2 | -200.36 Million CHF | -404.2% |
| 2013 Q4 | -205.76 Million CHF | -2.7% |
| 2013 FY | -205.76 Million CHF | -412.4% |
| 2012 Q4 | 65.86 Million CHF | 179.26% |
| 2012 FY | 65.86 Million CHF | -36.03% |
| 2012 Q2 | -83.09 Million CHF | -180.7% |
| 2011 FY | 102.96 Million CHF | -21.9% |
| 2011 Q4 | 102.96 Million CHF | 163.45% |
| 2011 Q2 | -162.28 Million CHF | -223.1% |
| 2010 FY | 131.83 Million CHF | 161.13% |
| 2010 Q4 | 131.83 Million CHF | 0.0% |
| 2009 FY | -215.65 Million CHF | 27.27% |
| 2008 FY | -296.52 Million CHF | -4.31% |
| 2007 FY | -284.27 Million CHF | -70.41% |
| 2006 FY | -166.82 Million CHF | -101.46% |
| 2005 FY | -82.8 Million CHF | -127.99% |
| 2004 FY | -36.31 Million CHF | -161.02% |
| 2003 FY | 59.51 Million CHF | -35.73% |
| 2002 FY | 92.6 Million CHF | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 4983.42% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 18300100.0% |
| Össur hf. | 395.08 Million USD | -224.238% |
| QHSLab, Inc. | 1.72 Million USD | -73947.527% |
| Wellstar International, Inc. | 51.36 Million USD | -2393.822% |
| Össur hf. | 395.08 Million USD | -224.238% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | -405682.962% |
| Aurora Spine Corporation | 1.9 Million USD | -67050.507% |
| BrainsWay Ltd. | -10.32 Million USD | 12512.791% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | -8539.905% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -6967.18% |
| Vivos Inc. | -1.59 Million USD | 80550.321% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -262759.277% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 236889.861% |
| Zecotek Photonics Inc. | 2.76 Million USD | -46271.88% |
| Avitar, Inc. | 5.17 Million USD | -24672.019% |
| Nanomix Corporation | 11.38 Million USD | -11147.54% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 27844.262% |
| Theraclion SA | -5.86 Million EUR | 21943.164% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.68 Million USD | -75839.012% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -79423.628% |
| Lombard Medical, Inc. | 11.49 Million USD | -11043.976% |
| ALR Technologies Inc. | 19.14 Million USD | -6589.908% |
| Stratec SE | 119.12 Million USD | -975.347% |
| Vycor Medical, Inc. | 1.05 Million USD | -121557.39% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -2329202.664% |
| MicroPort Scientific Corporation | 673.58 Million USD | -90.177% |
| VMS Rehab Systems, Inc. | 133.52 USD | -959406730.437% |
| NewCardio, Inc. | 2.41 Million USD | -52942.907% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -87221.123% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -202937.157% |
| Odyssey Group International, Inc. | 2.1 Million USD | -60674.411% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -199994.658% |
| Wellness Center USA, Inc. | 3.98 Million USD | -32041.65% |
| SANUWAVE Health, Inc. | 30.14 Million USD | -4149.179% |
| IR-Med Inc. | -606 Thousand USD | 211486.139% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 9391.171% |
| Polarean Imaging plc | -5.94 Million USD | 21641.953% |
| United American Healthcare Corporation | -9.32 Million USD | 13834.32% |
| ECGI Holdings, Inc. | 3.17 Million USD | -40294.256% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -1374452.01% |
| Capital Group Holdings, Inc. | -3508.00 USD | 36516633.637% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -487680.731% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -591290.9% |
| Urologix, Inc. | 4.61 Million USD | -27657.313% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -30331.724% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -38354.068% |
| SS Innovations International, Inc. | 1.18 Million USD | -107969.802% |
| Qualis Innovations, Inc. | 6671.00 USD | -19202418.363% |
| Smith & Nephew plc | 2.77 Billion USD | 53.889% |
| NIOX Group Plc | -23.93 Million USD | 5452.576% |
| Fuse Medical, Inc. | 1.75 Million USD | -72870.871% |
| Broncus Holding Corporation | -81.42 Million USD | 1673.229% |
| Brain Scientific Inc. | 2.11 Million USD | -60445.305% |
| Pressure BioSciences, Inc. | 22.67 Million USD | -5548.873% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -3238264.891% |